{{Rsnum
|rsid=4958881
|Gene=TNIP1
|Chromosome=5
|position=151070675
|Orientation=plus
|GMAF=0.1938
|Gene_s=TNIP1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 13.3 | 85.8
| HCB | 0.0 | 10.9 | 89.1
| JPT | 0.0 | 17.7 | 82.3
| YRI | 29.9 | 46.9 | 23.1
| ASW | 17.5 | 50.9 | 31.6
| CHB | 0.0 | 10.9 | 89.1
| CHD | 0.0 | 9.2 | 90.8
| GIH | 0.0 | 9.9 | 90.1
| LWK | 24.5 | 57.3 | 18.2
| MEX | 0.0 | 29.3 | 70.7
| MKK | 21.2 | 47.4 | 31.4
| TSI | 1.0 | 22.5 | 76.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=22896740
|Title=Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study
|OA=1
}}

{{PMID Auto GWAS
  |PMID=23055271
  |Trait=Myasthenia gravis
  |Title=Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
  |RiskAllele=G
  |Pval=3E-10
  |OR=1.73
  |ORtxt=[1.46-2.06]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}